Tissue engineering and stem cells: Basic principles and applications in urology

International Journal of Urology

Volumn 17, Issue 12, 2010, Pages 964-973

  Shokeir, Ahmed A ^a   Harraz, Ahmed M ^a   El Din, Ahmed B Shehab ^a  

^a MANSOURA UNIVERSITY   (Egypt)

Author keywords

Stem cells; Tissue engineering; Urinary tract

Indexed keywords

BUSULFAN; CISPLATIN; INTERLEUKIN 12; SILICONE;

ACUTE KIDNEY FAILURE; ADULT STEM CELL; ALLOGENEIC STEM CELL TRANSPLANTATION; AUTOLOGOUS STEM CELL TRANSPLANTATION; BLADDER; BLADDER DISEASE; BLADDER RECONSTRUCTION; BONE MARROW STEM CELL TRANSPLANTATION; BONE MARROW TRANSPLANTATION; CELL PROLIFERATION; CHRONIC KIDNEY FAILURE; CLINICAL RESEARCH; CLINICAL TRIAL; EMBRYONIC STEM CELL; ERECTILE DYSFUNCTION; GRAFT INFECTION; HEMATOMA; HUMAN; IN VITRO STUDY; IN VIVO STUDY; KIDNEY; KIDNEY CARCINOMA; KIDNEY INJURY; KIDNEY PARENCHYMA; MALE INFERTILITY; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MULTIPOTENT STEM CELL; NERVE GRAFT; NERVE REGENERATION; NONHUMAN; PENIS PROSTHESIS; PEYRONIE DISEASE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROSTATE; PROSTATE CANCER; PROSTATECTOMY; REVIEW; SCIENTIST; SOMATIC CELL; STEM CELL; STEM CELL TRANSPLANTATION; STRESS INCONTINENCE; SUBURETHRAL SLING; SURAL NERVE GRAFTING; TESTIS; TISSUE ENGINEERING; TOTIPOTENT STEM CELL; UMBILICAL CORD; URETER; URETER DISEASE; URETHRA; URETHRA STRICTURE; URETHRA SURGERY; URINARY DIVERSION; URINARY TRACT; URINARY TRACT DISEASE; URINARY TRACT INJURY; URINE INCONTINENCE; UROGENITAL SYSTEM; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; HUMANS; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING; UROLOGY;

EID: 78649623013     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2010.02643.x     Document Type: Review

References (83)

1. Brehmer B, Rohrmann D, Becker C, Rau G, Jakse G. Different types of scaffolds for reconstruction of the urinary tract by tissue engineering. Urol. Int. 2007; 78: 23-9.
2. Atala A. Bioengineered tissues for urogenital repair in children. Pediatr. Res. 2008; 63: 569-75.
3. Fuchs E, Segre JA. Stem cells: a new lease on life. Cell 2000; 100: 143-55.
4. Chung Y, Klimanskaya I, Becker S et al. Embryonic and extraembryonic stem cell lines derived from single mouse blastomeres. Nature 2006; 439: 216-19.
5. Wang HS, Hung SC, Peng ST et al. Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord. Stem Cells 2004; 22: 1330-7.
6. Yen BL, Chien CC, Chen YC et al. Placenta-derived multipotent cells differentiate into neuronal and glial cells in vitro. Tissue Eng. Part A 2008; 14: 9-17.
7. Miki T, Strom SC. Amnion-derived pluripotent/multipotent stem cells. Stem Cell Rev. 2006; 2: 133-42.
8. Da Silva ML, Chagastelles PC, Nardi NB. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J. Cell Sci. 2006; 119: 2204-13.
9. Conrad S, Renninger M, Hennenlotter J et al. Generation of pluripotent stem cells from adult human testis. Nature 2008; 20: 456 344-9.
10. Collas P. Dedifferentiation of cells: new approaches. Cytotherapy 2007; 9: 236.
11. French AJ, Adams CA, Anderson LS, Kitchen JR, Hughes MR, Wood SH. Development of human cloned blastocysts following somatic cell nuclear transfer with adult fibroblasts. Stem Cells 2008; 26: 485-93.
12. Condic ML. Alternative sources of pluripotent stem cells: altered nuclear transfer. Cell Prolif. 2008; 41 (Suppl 1): 7-19.
13. Ambrosi DJ, Tanasijevic B, Kaur A et al. Genome-wide reprogramming in hybrids of somatic cells and embryonic stem cells. Stem Cells 2007; 25: 1104-13.
14. Collas P, Taranger CK. Epigenetic reprogramming of nuclei using cell extracts. Stem Cell Rev. 2006; 2: 309-17.
15. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126: 663-76.
16. Morigi M, Imberti B, Zoja C. Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure. J. Am. Soc. Nephrol. 2004; 15: 1794-804.
17. Duffield JS, Park KM, Hsiao LL et al. Restoration of tubular epithelial cells during repair of the postischemic kidney occurs independently of bone marrow-derived stem cells. J. Clin. Invest. 2005; 115: 1743-55.
18. Qian H, Yang H, Xu W et al. Bone marrow mesenchymal stem cells ameliorate rat acute renal failure by differentiation into renal tubular epithelial-like cells. Int. J. Mol. Med. 2008; 22: 325-32.
19. Chen J, Park H-C, Addabbo F et al. Kidney-derived mesenchymal stem cells contribute to vasculogenesis, angiogenesis and endothelial repair. Kidney Int. 2008; 74: 879-89.
20. Kudryavtsev YV, Kirpatovskii VI, Plotnikov EY et al. Morphological changes in the kidneys of rats with postischemic acute renal failure after intrarenal administration of fetal mesenchymal stem cells from human bone marrow. Bull. Exp. Biol. Med. 2009; 147: 113-19.
21. Ninichuk V, Gross O, Segerer S et al. Multipotent mesenchymal stem cells reduce interstitial fibrosis but do not delay progression of chronic kidney disease in collagen4A3-deficient mice. Kidney Int. 2006; 70: 121-9.
22. Soojeong C, Mooyong P, Jinkuk K, Seungduk H, Seongkyu P, Youkyoung L. The role of mesenchymal stem cells in the functional improvement of chronic renal failure. Stem Cells Dev. 2009; 18: 521-30.
23. Semedo P, Correa-Costa M, Cenedeze MA et al. Mesenchymal Stem Cells Attenuate Renal Fibrosis Through Immune Modulation and Remodeling Properties in a Rat Remnant Kidney Model. Stem Cells 2009; 27: 3063-73.
24. Drewa T, Joachimiak R, Kaznica A, Flisinski M, Brymora A, Manitius J. Bone marrow progenitors from animals with chronic renal failure lack capacity of in vitro proliferation. Transplant. Proc. 2008; 40: 1668-73.
25. Lanza RP, Chung HY, Yoo JJ et al. Generation of histocompatible tissues using nuclear transplantation. Nat. Biotechnol. 2002; 20: 689-96.
26. Yokoo T, Ohashi T, Shen J-S et al. Human mesenchymal stem cells in rodent whole-embryo culture are reprogrammed to contribute to kidney tissue. Proc. Natl. Acad. Sci. USA 2005; 102: 3296-300.
27. Tiranathanagul K, Dhawan V, Lytle IF et al. Tissue engineering of an implantable bioartificial hemofilter. ASAIO J. 2007; 53: 176-86.
28. Ross EA, Williams MJ, Hamazaki T et al. Embryonic Stem Cells Proliferate and Differentiate when Seeded into Kidney Scaffolds. J. Am. Soc. Nephrol. 2009; 20: 2338-47.
29. Gao P, Ding Q, Wu Z, Jiang H, Fang Z. Therapeutic potential of human mesenchymal stem cells producing IL-12 in a mouse xenograft model of renal cell carcinoma. Cancer Lett. 2009; 290: 157-66.
30. Osman Y, Shokeir A, Gabr M, El-Tabey N, Mohsen T, El-Baz M. Canine ureteral replacement with long acellular matrix tube: is it clinically applicable? J. Urol. 2004; 172: 1151-4.
31. Smith TG III, Gettman M, Lindberg G, Napper C, Pearle MS, Cadeddu JA. Ureteral replacement using porcine small intestine submucosa in a porcine model. Urology 2002; 60: 931-4.
32. El-Hakim A, Marcovich R, Chiu KY, Lee BR, Smith AD. Ureteral segmental replacement revisited. J. Endourol. 2005; 19: 1069-74.
33. Matsunuma H, Kagami H, Narita Y et al. Constructing a tissue-engineered ureter using a decellularized matrix with cultured uroepithelial cells and bone marrow-derived mononuclear cells. Tissue Eng. 2006; 12: 509-18.
34. Kajbafzadeh AM, Payabvash S, Salmasi AH et al. Time-dependent neovasculogenesis and regeneration of different bladder wall components in the bladder acellular matrix graft in rats. J. Surg. Res. 2007; 139: 189-202.
35. Kanematsu A, Yamamoto S, Noguchi T, Ozeki M, Tabata Y, Ogawa O. Bladder regeneration by bladder acellular matrix combined with sustained release of exogenous growth factor. J. Urol. 2003; 170: 1633-8.
36. Drewa T, Adamowicz J, Lysik J, Polaczek J, Pielichowski J. Chitosan scaffold enhances nerve regeneration within the in vitro reconstructed bladder wall: an animal study. Urol. Int. 2008; 81: 330-4.
37. Frimberger D, Morales N, Gearhart JD, Gearhart JP, Lakshmanan Y. Human embryoid body-derived stem cells in tissue engineering-enhanced migration in co-culture with bladder smooth muscle and urothelium. Urology 2006; 67: 1298-303.
38. Jack GS, Zhang R, Lee M, Xu Y, Wu BM, Rodríguez LV. Urinary bladder smooth muscle engineered from adipose stem cells and a three dimensional synthetic composite. Biomaterials 2009; 30: 3259-70.
39. Sharma AK, Fuller NJ, Sullivan RR et al. Defined populations of bone marrow derived mesenchymal stem and endothelial progenitor cells for bladder regeneration. J. Urol. 2009; 182 (4 Suppl): 1898-905.
40. Drewa T. Using hair-follicle stem cells for urinary bladder-wall regeneration. Regen. Med. 2008; 3: 939-44.
41. Zhang Y, McNeill E, Tian H et al. Urine derived cells are a potential source for urological tissue reconstruction. J. Urol. 2008; 180: 2226-33.
42. Atala A, Bauer SB, Soker S, Yoo JJ, Retik AB. Tissue-engineered autologous bladders for patients needing cystoplasty. Lancet 2006; 367: 1241-6.
43. Ringdén O, Uzunel M, Sundberg B et al. Tissue repair using allogeneic mesenchymal stem cells for hemorrhagic cystitis, pneumomediastinum and perforated colon. Leukemia 2007; 21: 2271-6.
44. Kwon D, Kim Y, Pruchnic R et al. Periurethral cellular injection: comparison of muscle-derived progenitor cells and fibroblasts with regard to efficacy and tissue contractility in an animal model of stress urinary incontinence. Urology 2006; 68: 449-54.
45. Cannon TW, Sweeney DD, Conway DA et al. A tissue-engineered suburethral sling in an animal model of stress urinary incontinence. BJU Int. 2005; 96: 664-9.
46. Strasser H, Marksteiner R, Margreiter E et al. Transurethral ultrasonography-guided injection of adult autologous stem cells versus transurethral endoscopic injection of collagen in treatment of urinary incontinence. World J. Urol. 2007; 25: 385-92.
47. Mitterberger M, Marksteiner R, Margreiter E et al. Adult Autologous myoblasts and fibroblasts for female stress incontinence: a 1-year follow-up in 123 patients. BJU Int. 2007; 100: 1081-5.
48. Mitterberger M, Marksteiner R, Margreiter E et al. Myoblast and fibroblast therapy for post-prostatectomy urinary incontinence: 1-year follow up of 63 patients. J. Urol. 2008; 179: 226-31.
49. Carr LK, Steele D, Steele S et al. 1-year follow-up of autologous muscle-derived stem cell injection pilot study to treat stress urinary incontinence. Int. Urogynecol. J. Pelvic Floor Dysfunct. 2008; 19: 881-3.
50. Kajbafzadeh AM, Elmi A, Payabvash S et al. Transurethral autologous myoblast injection for treatment of urinary incontinence in children with classic bladder exstrophy. J. Urol. 2008; 180: 1098-105.
51. Fu Q, Song XF, Liao GL, Deng CL, Cui L. Myoblasts differentiated from adipose-derived stem cells to treat stress urinary incontinence. Urology 2009; 75: 718-23.
52. Lin G, Wang G, Banie L et al. Treatment of stress urinary incontinence with adipose tissue-derived stem cells. Cytotherapy 2010; 12: 88-95.
53. Yamamoto T, Gotoh M, Hattori R et al. Periurethral injection of autologous adipose-derived stem cells for the treatment of stress urinary incontinence in patients undergoing radical prostatectomy: report of two initial cases. Int. J. Urol. 2009; 17: 75-82.
54. El-Kassaby A, AbouShwareb T, Atala A. Randomized comparative study between buccal mucosal and acellular bladder matrix grafts in complex anterior urethral strictures. J. Urol. 2008; 179: 1432-6.
55. Li C, Xu YM, Song LJ, Fu Q, Cui L, Yin S. Urethral reconstruction using oral keratinocyte seeded bladder acellular matrix grafts. J. Urol. 2008; 180: 1538-42.
56. Shokeir AA, Osman Y, El-Azab M, Gabr M, Dawaba M, El-Baz M. Tunica albuginea acellular matrix graft for treatment of Peyronie's disease - an experimental study in dogs. Scand. J. Urol. Nephrol. 2004; 38: 499-503.
57. Breyer BN, Brant WO, Garcia MM, Bella AJ, Lue TF. Complications of porcine small intestine submucosa graft for Peyronie's disease. J. Urol. 2007; 177: 589-91.
58. Falke G, Yoo JJ, Kwon TG, Moreland R, Atala A. Formation of corporal tissue architecture in vivo using human cavernosal muscle and endothelial cells seeded on collagen matrices. Tissue Eng. 2003; 9: 871-9.
59. May F, Weidner N, Matiasek K et al. Schwann cell seeded guidance tubes restore erectile function after ablation of cavernous nerves in rats. J. Urol. 2004; 172: 374-7.
60. Connolly SS, Yoo JJ, Abouheba M, Soker S, McDougal WS, Atala A. Cavernous nerve regeneration using acellular nerve grafts. World J. Urol. 2008; 26: 333-9.
61. Kim ED, Scardino PT, Hampel O, Mills NL, Wheeler TM, Nath RK. Interposition of sural nerve restores function of cavernous nerves resected during radical prostatectomy. J. Urol. 1999; 161: 188-92.
62. Kim ED, Nath R, Slawin KM, Kadmon D, Miles BJ, Scardino PT. Bilateral nerve grafting during radical retropubic prostatectomy: extended follow-up. Urology 2001; 58: 983-7.
63. Singh H, Karakiewicz P, Shariat SF et al. Impact of unilateral interposition sural nerve grafting on recovery of urinary function after radical prostatectomy. Urology 2004; 63: 1122-7.
64. Sim HG, Kliot M, Lange PH, Ellis WJ, Takayama TK, Yang CC. Two-year outcome of unilateral sural nerve interposition graft after radical prostatectomy. Urology 2006; 68: 1290-4.
65. Chang DW, Wood CG, Kroll SS, Youssef AA, Babaian RJ. Cavernous nerve reconstruction to preserve erectile function following non-nerve-sparing radical retropubic prostatectomy: a prospective study. Plast. Reconstr. Surg. 2003; 111: 1174-81.
66. Secin FP, Koppie TM, Scardino PT et al. Bilateral cavernous nerve interposition grafting during radical retropubic prostatectomy: Memorial Sloan-Kettering Cancer Center experience. J. Urol. 2007; 177: 664-8.
67. Namiki S, Saito S, Nakagawa H, Sanada T, Yamada A, Arai Y. Impact of unilateral sural nerve graft on recovery of potency and continence following radical prostatectomy: 3-year longitudinal study. J. Urol. 2007; 178: 212-16; discussion 216.
68. Fujioka M, Tasaki I, Kitamura R et al. Cavernous nerve graft reconstruction using an autologous nerve guide to restore potency. BJU Int. 2007; 100: 1107-9.
69. Davis JW, Chang DW, Chevray P et al. Randomized phase II trial evaluation of erectile function after attempted unilateral cavernous nerve-sparing retropubic radical prostatectomy with versus without unilateral sural nerve grafting for clinically localized prostate cancer. Eur. Urol. 2009; 55: 1135-43.
70. Bochinski D, Lin GT, Nunes L et al. The effect of neural embryonic stem cell therapy in a rat model of cavernosal nerve injury. BJU Int. 2004; 94: 904-9.
71. Bivalacqua TJ, Deng W, Kendirci M et al. Mesenchymal stem cells alone or ex vivo gene modified with endothelial nitric oxide synthase reverse age-associated erectile dysfunction. Am. J. Physiol. Heart Circ. Physiol. 2007; 292: H1278-H1290.
72. Song YS, Ku JH, Song ES et al. Magnetic resonance evaluation of human mesenchymal stem cells in corpus cavernosa of rats and rabbits. Asian J. Androl. 2007; 9: 361-7.
73. Toyooka Y, Tsunekawa N, Akasu R, Noce T. Embryonic stem cells can form germ cells in vitro. Proc. Natl. Acad. Sci. USA 2003; 100: 11457-62.
74. West JA, Park IH, Daley GQ, Geijsen N. In vitro generation of germ cells from murine embryonic stem cells. Nat. Protoc. 2006; 1: 2026-36.
75. Nayernia K, Lee JH, Drusenheimer N et al. Derivation of male germ cells from bone marrow stem cells. Lab. Invest. 2006; 86: 654-63.
76. Drusenheimer N, Wulf G, Nolte J et al. Putative human male germ cells from bone marrow stem cells. Soc. Reprod. Fertil. Suppl. 2007; 63: 69-76.
77. Lue Y, Erkkila K, Liu PY et al. Fate of bone marrow stem cells transplanted into the testis: potential implication for men with testicular failure. Am. J. Pathol. 2007; 170: 899-908.
78. Yu RN, Estrada CR. Stem cells: a review and implications for urology. Urology 2010; 75: 664-70.
79. Montzka K, Heidenreich A. Application of mesenchymal stromal cells in urological diseases. BJU Int. 2010; 105: 309-12.
80. Garcia MM, Fandel TM, Lin G et al. Treatment of erectile dysfunction in the obese type 2 diabetic ZDF rat with adipose tissue-derived stem cells. J. Sex. Med. 2010; 7 (1 Pt 1): 89-98.
81. Huang YC, Shindel AW, Ning H et al. Adipose derived stem cells ameliorate hyperlipidemia associated detrusor overactivity in a rat model. J. Urol. 2010; 183: 1232-40.
82. Harraz A, Shindel AW, Lue TF. Emerging gene and stem cell therapies for the treatment of erectile dysfunction. Nat. Rev. Urol. 2010; 7: 143-52.
83. Nikolavsky D, Chancellor MB. Stem cell therapy for stress urinary incontinence. Neurourol. Urodyn. 2010; 29 (Suppl 1): S36-S41.